A new protein containing an SH2 domain that inhibits JAK kinases (original) (raw)
- Letter
- Published: 26 June 1997
- Masaaki Masuhara1 na1,
- Masahiro Yokouchi1,2 na1,
- Ritsu Suzuki1,2,
- Hiroshi Sakamoto1,
- Kaoru Mitsui1,
- Akira Matsumoto1,
- Shyu Tanimura1,
- Motoaki Ohtsubo1,
- Hiroyuki Misawa1,
- Tadaaki Miyazaki3,
- Nogueira Leonor3,
- Tadatsugu Taniguchi3,
- Takashi Fujita4,
- Yuzuru Kanakura5 na1,
- Seturo Komiya2 &
- …
- Akihiko Yoshimura1
Nature volume 387, pages 921–924 (1997)Cite this article
- 4460 Accesses
- 9 Altmetric
- Metrics details
Abstract
The proliferation and differentiation of cells of many lineages are regulated by secreted proteins known as cytokines. Cytokines exert their biological effect through binding to cell-surface receptors that are associated with one or more members of the JAK family of cytoplasmic tyrosine kinases. Cytokine-induced receptor dimerization leads to the activation of JAKs, rapid tyrosine-phosphorylation of the cytoplasmic domains, and subsequent recruitment of various signalling proteins, including members of the STAT family of transcription factors, to the receptor complex1,2,3,4,5. Using the yeast two-hybrid system, we have now isolated a new SH2-domain-containing protein, JAB, which is a JAK-binding protein that interacts with the Jak2 tyrosine-kinase JH1 domain6. JAB is structurally related to CIS, a cytokine-inducible SH2 protein7,8. Interaction of JAB with Jak1, Jak2 or Jak3 markedly reduces their tyrosine-kinase activity and suppresses the tyrosine-phosphorylation and activation of STATs. JAB and CIS appear to function as negative regulators in the JAK signalling pathway.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
References
- Miyajima, A., Kitamura, T., Harada, N., Yokota, T. & Arai, K. Cytokine receptors and signal transduction. Annu. Rev. Immunol. 10, 295–331 (1992).
Article CAS PubMed Google Scholar - Schindler, C. & Darnell, J. E. J Transcriptional responses to polypeptide ligands: the JAK–STAT pathway. Annu. Rev. Biochem. 64, 621–651 (1995).
Article CAS PubMed Google Scholar - Ihle, J. N. Cytokine receptor signalling. Nature 377, 591–594 (1995).
Article ADS CAS PubMed Google Scholar - Ihle, J. N. STATs: Signal transducers and activators of transcription. Cell 84, 331–334 (1996).
Article CAS PubMed Google Scholar - Darnell, J. E. J., Kerr, I. M. & Stark, G. R. Jak–STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415–1421 (1994).
Article ADS CAS PubMed Google Scholar - Harpur, A. G., Andres, A. C., Ziemiecki, A., Aston, R. R. & Wilks, A. F. JAK2, a third member of the JAK family of protein tyrosine kinases. Oncogene 7, 1347–1353 (1992).
CAS PubMed Google Scholar - Yoshimura, A. et al. Anovel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin-3 and erythropoietin receptors. EMBO J. 14, 2816–2816 (1995).
Article CAS PubMed PubMed Central Google Scholar - Matsumoto, A. et al. CIS, a cytokine inducible SH2 protein, is a target of the JAK–STAT5 pathway and modulates STAT5 activation. Blood 89, 3148–3154 (1997).
CAS PubMed Google Scholar - Schluter, G. et al. Sequence analysis of the conserved protamine gene cluster shows that it contains a fourth expressed gene. Mol. Reprod. Dvelop. 43, 1–6 (1996).
Article CAS Google Scholar - Kitayama, H. et al. Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. Blood 85, 790–798 (1995).
CAS PubMed Google Scholar - Feng, J. et al. Activation of JAK2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop. Mol. Cell. Biol. 17, 2497–2501 (1997).
Article CAS PubMed PubMed Central Google Scholar - Nakajima, K. et al. Acentral role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J. 15, 3651–3658 (1996).
Article CAS PubMed PubMed Central Google Scholar - Kawahara, A., Minami, Y., Miyazaki, T., Ihle, J. N. & Taniguchi, T. Critical role of the interleukin 2 (IL-2) receptor gamma-chain-associated Jak3 in the IL2-induced c-fos and c-myc, but not bcl-2, gene induction. Proc. Natl Acad. Sci. USA 92, 8721–8728 (1995).
Article ADS Google Scholar - Vojtek, A. B., Hollenberg, S. M. & Cooper, J. A. Mammalian Ras interacts directly with serine/threonine kinase Raf. Cell 74, 205–214 (1993).
Article CAS PubMed Google Scholar - Briscoe, J. et al. Kinase-negative mutants of JAK1 can sustain interferon-γ-inducible gene expression but not an antiviral state. EMBO J. 15, 799–809 (1996).
Article CAS PubMed PubMed Central Google Scholar - Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. & Elledge, S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinase. Cell 75, 805–816 (1993).
Article CAS PubMed Google Scholar - Turner, D. L. & Weintraub, H. Expression of achaete-scute homolog 3 in Xenopus embryos converts ectodermal cells to a neural fate. Genes Dev. 8, 1434–1447 (1994).
Article CAS PubMed Google Scholar - Starr, R. et al. Afamily of cytokine-inducible inhibitors of signalling. Nature 387, 917–921 (1997).
Article ADS CAS PubMed Google Scholar - Naka, T. et al. Structure and function of a new STAT-induced STAT inhibitor. Nature 387, 924–929 (1997).
Article ADS CAS PubMed Google Scholar
Acknowledgements
We thank H. Ohgusu for technical assistance, T. Hirano for the APRE/jun promoter construct and STAT3 cDNA, R. Fukunaga for Jak2, A. F. Wilks for the Jak1, T. Shirasawa for rat Jak3 cDNAs, and D. Hilton and R. Starr for reading and editing the manuscript. Part of this work was supported by grants from the Ministry of Science, Education and Culture of Japan, the Kato Memorial Foundation, the Haraguchi Memorial Foundation, the Uehara Memorial Foundation, the Kowa Life Science Foundation, the Motida Memorial Science Foundation and the Naito Memorial Foundation.
Author information
Author notes
- Takaho A. Endo, Masaaki Masuhara, Masahiro Yokouchi and Yuzuru Kanakura: These authors contributed equally to this work.
Authors and Affiliations
- *Institute of Life Science, Kurume University, Aikawamachi 2432-3, 839, Kurume, Japan
Takaho A. Endo, Masaaki Masuhara, Masahiro Yokouchi, Ritsu Suzuki, Hiroshi Sakamoto, Kaoru Mitsui, Akira Matsumoto, Shyu Tanimura, Motoaki Ohtsubo, Hiroyuki Misawa & Akihiko Yoshimura - ‡Department of Orthopedic Surgery, Kurume University, Aikawamachi 2432-3, 839, Kurume, Japan
Masahiro Yokouchi, Ritsu Suzuki & Seturo Komiya - §Department of Immunology, Faculty of Medicine, University of Tokyo, Bunkyo-ku, 113, Tokyo, Japan
Tadaaki Miyazaki, Nogueira Leonor & Tadatsugu Taniguchi - ‖Department of Tumor Cell Biology, The Tokyo Metropolitan Institute of Medical Science, Bunkyouku, 113, Tokyo, Japan
Takashi Fujita - ¶Department of Hematology and Oncology, Osaka University Medical School, 565, Suita, Japan
Yuzuru Kanakura
Authors
- Takaho A. Endo
You can also search for this author inPubMed Google Scholar - Masaaki Masuhara
You can also search for this author inPubMed Google Scholar - Masahiro Yokouchi
You can also search for this author inPubMed Google Scholar - Ritsu Suzuki
You can also search for this author inPubMed Google Scholar - Hiroshi Sakamoto
You can also search for this author inPubMed Google Scholar - Kaoru Mitsui
You can also search for this author inPubMed Google Scholar - Akira Matsumoto
You can also search for this author inPubMed Google Scholar - Shyu Tanimura
You can also search for this author inPubMed Google Scholar - Motoaki Ohtsubo
You can also search for this author inPubMed Google Scholar - Hiroyuki Misawa
You can also search for this author inPubMed Google Scholar - Tadaaki Miyazaki
You can also search for this author inPubMed Google Scholar - Nogueira Leonor
You can also search for this author inPubMed Google Scholar - Tadatsugu Taniguchi
You can also search for this author inPubMed Google Scholar - Takashi Fujita
You can also search for this author inPubMed Google Scholar - Yuzuru Kanakura
You can also search for this author inPubMed Google Scholar - Seturo Komiya
You can also search for this author inPubMed Google Scholar - Akihiko Yoshimura
You can also search for this author inPubMed Google Scholar
Corresponding author
Correspondence toAkihiko Yoshimura.
Rights and permissions
About this article
Cite this article
Endo, T., Masuhara, M., Yokouchi, M. et al. A new protein containing an SH2 domain that inhibits JAK kinases.Nature 387, 921–924 (1997). https://doi.org/10.1038/43213
- Received: 17 March 1997
- Accepted: 02 May 1997
- Issue Date: 26 June 1997
- DOI: https://doi.org/10.1038/43213